Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Stankiewicz

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Forum of Allergy & Rhinology|February 17, 2012
Two-year results: transantral balloon dilation of the ethmoid infundibulumJames Stankiewicz, Theodore Truitt, James Atkins, et al.
Seminars in Neurology|October 10, 2008
Neuroimaging of toxic and metabolic disordersAshish Arora, Mohit Neema, James Stankiewicz, et al.
Multiple Sclerosis and Related Disorders|March 19, 2025
Immune response to influenza vaccine in patients with relapsing multiple sclerosis treated with ofatumumab: Results from an open-label, multicenter, phase 4 studyBrian Steingo, Adnan Subei, Emily Riser, et al.
BMC Neurology|July 12, 2022
Comparison of dimethyl fumarate and interferon outcomes in an MS cohortNeda Sattarnezhad, Brian C Healy, Moogeh Baharnoori, et al.
American Journal of Rhinology|January 31, 2004
Intravenous antibiotics for refractory rhinosinusitis in nonsurgical patients: preliminary findings of a prospective studyVijay Anand, Howard Levine, Michael Friedman, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 12, 2007
T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosisMohit Neema, James Stankiewicz, Ashish Arora, et al.
International Forum of Allergy & Rhinology|January 31, 2012
Impact of chronic rhinosinusitis on work productivity through one-year follow-up after balloon dilation of the ethmoid infundibulumJames Stankiewicz, Thomas Tami, Theodore Truitt, et al.
Multiple Sclerosis and Related Disorders|September 28, 2023
Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumabAmit Bar-Or, Rany Aburashed, Angel R Chinea, et al.
International Forum of Allergy & Rhinology|December 7, 2011
First clinic experience: patient selection and outcomes for ostial dilation for chronic rhinosinusitisJeffrey Cutler, Theodore Truitt, James Atkins, et al.
International Forum of Allergy & Rhinology|June 28, 2012
Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study with 1-year follow-upTimothy L Smith, Robert Kern, James N Palmer, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Forum of Allergy & Rhinology|February 17, 2012
Two-year results: transantral balloon dilation of the ethmoid infundibulumJames Stankiewicz, Theodore Truitt, James Atkins, et al.
Seminars in Neurology|October 10, 2008
Neuroimaging of toxic and metabolic disordersAshish Arora, Mohit Neema, James Stankiewicz, et al.
Multiple Sclerosis and Related Disorders|March 19, 2025
Immune response to influenza vaccine in patients with relapsing multiple sclerosis treated with ofatumumab: Results from an open-label, multicenter, phase 4 studyBrian Steingo, Adnan Subei, Emily Riser, et al.
BMC Neurology|July 12, 2022
Comparison of dimethyl fumarate and interferon outcomes in an MS cohortNeda Sattarnezhad, Brian C Healy, Moogeh Baharnoori, et al.
American Journal of Rhinology|January 31, 2004
Intravenous antibiotics for refractory rhinosinusitis in nonsurgical patients: preliminary findings of a prospective studyVijay Anand, Howard Levine, Michael Friedman, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 12, 2007
T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosisMohit Neema, James Stankiewicz, Ashish Arora, et al.
International Forum of Allergy & Rhinology|January 31, 2012
Impact of chronic rhinosinusitis on work productivity through one-year follow-up after balloon dilation of the ethmoid infundibulumJames Stankiewicz, Thomas Tami, Theodore Truitt, et al.
Multiple Sclerosis and Related Disorders|September 28, 2023
Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumabAmit Bar-Or, Rany Aburashed, Angel R Chinea, et al.
International Forum of Allergy & Rhinology|December 7, 2011
First clinic experience: patient selection and outcomes for ostial dilation for chronic rhinosinusitisJeffrey Cutler, Theodore Truitt, James Atkins, et al.
International Forum of Allergy & Rhinology|June 28, 2012
Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study with 1-year follow-upTimothy L Smith, Robert Kern, James N Palmer, et al.
Pageof 3